Global siRNA Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA at first non-coding RNA molecules, typically 20–24 (normally 21) base pairs in length, similar to miRNA, and operating within the RNA interference (RNAi) pathway. siRNA plays a crucial role in gene silencing and regulation of gene expression. siRNA-based therapeutics have gained significant attention in recent years due to their potential to target specific genes involved in diseases such as cancer, genetic disorders, viral infections, and neurodegenerative diseases. The scope of siRNA drug products encompasses various aspects, including their design, development, testing, and regulatory approval.

According to our (Global Info Research) latest study, the global siRNA Drugs market size was valued at US$ 1643 million in 2023 and is forecast to a readjusted size of USD 12820 million by 2030 with a CAGR of 31.2% during review period.

Core manufacturers of siRNA Drugs include Alnylam, Novartis, Novo Nordisk, Genzyme and Arrowhead. USA is the largest consumption region, accounting for approximately 57% of the global market, followed by Europe. In terms of product type, subcutaneous injection are the largest market segment, with a share of more than 77%. In terms of product application, the largest application market is nervous system therapy, with a share of approximately 52%.

This report is a detailed and comprehensive analysis for global siRNA Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global siRNA Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
Global siRNA Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global siRNA Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global siRNA Drugs market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for siRNA Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global siRNA Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Novartis, Novo Nordisk, Genzyme, Arrowhead, Silence, Sylentis, Avidity Biosciences, Sirnaomics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
siRNA Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
siRNA Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Intravenous Injection
    Subcutaneous Injection

Market segment by Application
    Nervous System Therapy
    Endocrine and Metabolic Therapy
    Others

Market segment by players, this report covers
    Alnylam
    Novartis
    Novo Nordisk
    Genzyme
    Arrowhead
    Silence
    Sylentis
    Avidity Biosciences
    Sirnaomics

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe siRNA Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of siRNA Drugs, with revenue, gross margin, and global market share of siRNA Drugs from 2019 to 2024.
Chapter 3, the siRNA Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and siRNA Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of siRNA Drugs.
Chapter 13, to describe siRNA Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of siRNA Drugs
    1.2 Classification of siRNA Drugs by Type
        1.2.1 Overview: Global siRNA Drugs Market Size by Type: 2024 Versus 2030
        1.2.2 Global siRNA Drugs Revenue Market Share by Type in 2030
        1.2.3 Intravenous Injection
        1.2.4 Subcutaneous Injection
    1.3 Global siRNA Drugs Market by Application
        1.3.1 Overview: Global siRNA Drugs Market Size by Application: 2024 Versus 2030
        1.3.2 Nervous System Therapy
        1.3.3 Endocrine and Metabolic Therapy
        1.3.4 Others
    1.4 Global siRNA Drugs Market Size & Forecast
    1.5 Market Drivers, Restraints and Trends
        1.5.1 siRNA Drugs Market Drivers
        1.5.2 siRNA Drugs Market Restraints
        1.5.3 siRNA Drugs Trends Analysis

2 Company Profiles
    2.1 Alnylam
        2.1.1 Alnylam Details
        2.1.2 Alnylam Major Business
        2.1.3 Alnylam siRNA Drugs Product and Solutions
        2.1.4 Alnylam Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis siRNA Drugs Product and Solutions
        2.2.4 Novartis Recent Developments and Future Plans
    2.3 Novo Nordisk
        2.3.1 Novo Nordisk Details
        2.3.2 Novo Nordisk Major Business
        2.3.3 Novo Nordisk siRNA Drugs Product and Solutions
        2.3.4 Novo Nordisk Recent Developments and Future Plans
    2.4 Genzyme
        2.4.1 Genzyme Details
        2.4.2 Genzyme Major Business
        2.4.3 Genzyme siRNA Drugs Product and Solutions
        2.4.4 Genzyme Recent Developments and Future Plans
    2.5 Arrowhead
        2.5.1 Arrowhead Details
        2.5.2 Arrowhead Major Business
        2.5.3 Arrowhead siRNA Drugs Product and Solutions
        2.5.4 Arrowhead Recent Developments and Future Plans
    2.6 Silence
        2.6.1 Silence Details
        2.6.2 Silence Major Business
        2.6.3 Silence siRNA Drugs Product and Solutions
        2.6.4 Silence Recent Developments and Future Plans
    2.7 Sylentis
        2.7.1 Sylentis Details
        2.7.2 Sylentis Major Business
        2.7.3 Sylentis siRNA Drugs Product and Solutions
        2.7.4 Sylentis Recent Developments and Future Plans
    2.8 Avidity Biosciences
        2.8.1 Avidity Biosciences Details
        2.8.2 Avidity Biosciences Major Business
        2.8.3 Avidity Biosciences siRNA Drugs Product and Solutions
        2.8.4 Avidity Biosciences Recent Developments and Future Plans
    2.9 Sirnaomics
        2.9.1 Sirnaomics Details
        2.9.2 Sirnaomics Major Business
        2.9.3 Sirnaomics siRNA Drugs Product and Solutions
        2.9.4 Sirnaomics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global siRNA Drugs Revenue and Share by Players (2024 & 2030)
    3.2 siRNA Drugs Players Head Office, Products and Services Provided
    3.3 siRNA Drugs Mergers & Acquisitions
    3.4 siRNA Drugs New Entrants and Expansion Plans

4 Global siRNA Drugs Forecast by Region
    4.1 Global siRNA Drugs Market Size by Region: 2024 VS 2030
    4.2 Global siRNA Drugs Market Size by Region, (2024-2030)
    4.3 North America
        4.3.1 Key Companies of siRNA Drugs in North America
        4.3.2 Current Situation and Forecast of siRNA Drugs in North America
        4.3.3 North America siRNA Drugs Market Size and Prospect (2024-2030)
    4.4 Europe
        4.4.1 Key Companies of siRNA Drugs in Europe
        4.4.2 Current Situation and Forecast of siRNA Drugs in Europe
        4.4.3 Europe siRNA Drugs Market Size and Prospect (2024-2030)
    4.5 Asia-Pacific
        4.5.1 Key Companies of siRNA Drugs in Asia-Pacific
        4.5.2 Current Situation and Forecast of siRNA Drugs in Asia-Pacific
        4.5.3 Asia-Pacific siRNA Drugs Market Size and Prospect (2024-2030)
        4.5.4 China
        4.5.5 Japan
        4.5.6 South Korea
    4.6 South America
        4.6.1 Key Companies of siRNA Drugs in South America
        4.6.2 Current Situation and Forecast of siRNA Drugs in South America
        4.6.3 South America siRNA Drugs Market Size and Prospect (2024-2030)
    4.7 Middle East & Africa
        4.7.1 Key Companies of siRNA Drugs in Middle East & Africa
        4.7.2 Current Situation and Forecast of siRNA Drugs in Middle East & Africa
        4.7.3 Middle East & Africa siRNA Drugs Market Size and Prospect (2024-2030)

5 Market Size Segment by Type
    5.1 Global siRNA Drugs Market Forecast by Type (2024-2030)
    5.2 Global siRNA Drugs Market Share Forecast by Type (2024-2030)

6 Market Size Segment by Application
    6.1 Global siRNA Drugs Market Forecast by Application (2024-2030)
    6.2 Global siRNA Drugs Market Share Forecast by Application (2024-2030)

7 Research Findings and Conclusion

8 Appendix
    8.1 Methodology
    8.2 Research Process and Data Source
    8.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global siRNA Drugs Revenue by Type, (USD Million) 2024 VS 2030
 Table 2. Global siRNA Drugs Revenue by Application, (USD Million), 2024 VS 2030
 Table 3. Alnylam Corporate Information, Head Office, and Major Competitors
 Table 4. Alnylam Major Business
 Table 5. Alnylam siRNA Drugs Product and Solutions
 Table 6. Novartis Corporate Information, Head Office, and Major Competitors
 Table 7. Novartis Major Business
 Table 8. Novartis siRNA Drugs Product and Solutions
 Table 9. Novo Nordisk Corporate Information, Head Office, and Major Competitors
 Table 10. Novo Nordisk Major Business
 Table 11. Novo Nordisk siRNA Drugs Product and Solutions
 Table 12. Genzyme Corporate Information, Head Office, and Major Competitors
 Table 13. Genzyme Major Business
 Table 14. Genzyme siRNA Drugs Product and Solutions
 Table 15. Arrowhead Corporate Information, Head Office, and Major Competitors
 Table 16. Arrowhead Major Business
 Table 17. Arrowhead siRNA Drugs Product and Solutions
 Table 18. Silence Corporate Information, Head Office, and Major Competitors
 Table 19. Silence Major Business
 Table 20. Silence siRNA Drugs Product and Solutions
 Table 21. Sylentis Corporate Information, Head Office, and Major Competitors
 Table 22. Sylentis Major Business
 Table 23. Sylentis siRNA Drugs Product and Solutions
 Table 24. Avidity Biosciences Corporate Information, Head Office, and Major Competitors
 Table 25. Avidity Biosciences Major Business
 Table 26. Avidity Biosciences siRNA Drugs Product and Solutions
 Table 27. Sirnaomics Corporate Information, Head Office, and Major Competitors
 Table 28. Sirnaomics Major Business
 Table 29. Sirnaomics siRNA Drugs Product and Solutions
 Table 30. Global siRNA Drugs Revenue (USD Million) by Players (2024 & 2030)
 Table 31. Global siRNA Drugs Revenue Share by Players (2024 & 2030)
 Table 32. siRNA Drugs Players Head Office, Products and Services Provided
 Table 33. siRNA Drugs Mergers & Acquisitions in the Past Five Years
 Table 34. siRNA Drugs New Entrants and Expansion Plans
 Table 35. Global Market siRNA Drugs Revenue (USD Million) Comparison by Region (2024 VS 2030)
 Table 36. Global siRNA Drugs Revenue Market Share by Region (2024-2030)
 Table 37. Key Companies of siRNA Drugs in North America
 Table 38. Current Situation and Forecast of siRNA Drugs in North America
 Table 39. Key Companies of siRNA Drugs in Europe
 Table 40. Current Situation and Forecast of siRNA Drugs in Europe
 Table 41. Key Companies of siRNA Drugs in Asia-Pacific
 Table 42. Current Situation and Forecast of siRNA Drugs in Asia-Pacific
 Table 43. Key Companies of siRNA Drugs in China
 Table 44. Key Companies of siRNA Drugs in Japan
 Table 45. Key Companies of siRNA Drugs in South Korea
 Table 46. Key Companies of siRNA Drugs in South America
 Table 47. Current Situation and Forecast of siRNA Drugs in South America
 Table 48. Key Companies of siRNA Drugs in Middle East & Africa
 Table 49. Current Situation and Forecast of siRNA Drugs in Middle East & Africa
 Table 50. Global siRNA Drugs Revenue Forecast by Type (2024-2030)
 Table 51. Global siRNA Drugs Revenue Forecast by Application (2024-2030)


List of Figures
 Figure 1. siRNA Drugs Picture
 Figure 2. Global siRNA Drugs Revenue Market Share by Type in 2030
 Figure 3. Intravenous Injection
 Figure 4. Subcutaneous Injection
 Figure 5. siRNA Drugs Revenue Market Share by Application in 2030
 Figure 6. Nervous System Therapy Picture
 Figure 7. Endocrine and Metabolic Therapy Picture
 Figure 8. Others Picture
 Figure 9. Global siRNA Drugs Market Size, (USD Million): 2024 VS 2030
 Figure 10. Global siRNA Drugs Revenue and Forecast (2024-2030) & (USD Million)
 Figure 11. siRNA Drugs Market Drivers
 Figure 12. siRNA Drugs Market Restraints
 Figure 13. siRNA Drugs Market Trends
 Figure 14. Alnylam Recent Developments and Future Plans
 Figure 15. Novartis Recent Developments and Future Plans
 Figure 16. Novo Nordisk Recent Developments and Future Plans
 Figure 17. Genzyme Recent Developments and Future Plans
 Figure 18. Arrowhead Recent Developments and Future Plans
 Figure 19. Silence Recent Developments and Future Plans
 Figure 20. Sylentis Recent Developments and Future Plans
 Figure 21. Avidity Biosciences Recent Developments and Future Plans
 Figure 22. Sirnaomics Recent Developments and Future Plans
 Figure 23. Global siRNA Drugs Revenue Market Share by Region (2024-2030)
 Figure 24. Global siRNA Drugs Revenue Market Share by Region in 2030
 Figure 25. North America siRNA Drugs Revenue (USD Million) and Growth Rate (2024-2030)
 Figure 26. Europe siRNA Drugs Revenue (USD Million) and Growth Rate (2024-2030)
 Figure 27. Asia-Pacific siRNA Drugs Revenue (USD Million) and Growth Rate (2024-2030)
 Figure 28. South America siRNA Drugs Revenue (USD Million) and Growth Rate (2024-2030)
 Figure 29. Middle East & Africa siRNA Drugs Revenue (USD Million) and Growth Rate (2024-2030)
 Figure 30. Global siRNA Drugs Market Share Forecast by Type (2024-2030)
 Figure 31. Global siRNA Drugs Market Share Forecast by Application (2024-2030)
 Figure 32. Methodology
 Figure 33. Research Process and Data Source

Companies Mentioned

Alnylam
Novartis
Novo Nordisk
Genzyme
Arrowhead
Silence
Sylentis
Avidity Biosciences
Sirnaomics